Navigation Links
Taking the gamble out of DNA sequencing
Date:2/24/2013

-recapture. In this model, individuals are captured and tagged so that a recapture of the same individual will be known and the number of times each individual was captured can be used to make inferences about the population as a whole.

In this way scientists can estimate, for example, the number of gorillas remaining in the wild. In DNA sequencing, the individuals are the various different genomic molecules in a sample. However, the mathematical models used for counting gorillas don't work on the scale of DNA sequencing.

"The basic model has been known for decades, but the way it has been used makes it highly unstable in most applications. We took a different approach that depends on lots of computing power and seems to work best in large-scale applications like modern DNA sequencing," Daley said.

Scientists faced a similar problem in the early days of the human genome sequencing project. A mathematical solution was provided by Michael Waterman of USC, in 1988, which found widespread use. Recent advances in sequencing technology, however, require thinking differently about the mathematical properties of DNA sequencing data.

"Huge data sets required a novel approach. I'm very please it was developed here at USC," said Waterman.


'/>"/>

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California
Source:Eurekalert

Page: 1 2

Related biology news :

1. Taking the pulse of volcanoes using satellite images
2. Taking a hit or 2
3. Taking Americas rarest snake back to the woods
4. Young researcher taking fight against global killer to the next level in Vietnam
5. An invasive Asian fly is taking over European fruit
6. Seals gamble with their pups futures
7. Sequencing hundreds of chloroplast genomes now possible
8. Researchers develop tool to evaluate genome sequencing method
9. Genetic sequencing breakthrough to aid treatment for congenital hyperinsulinism
10. Gene sequencing project identifies abnormal gene that launches rare childhood leukemia
11. Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... its touch fingerprint sensor FPC1025 from the distributor World ... will commence during Q2 2015 although the major part ... The sensors will be used by smartphone manufacturers in ... 110 MSEK is included in the communicated revenue guidance ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... Mayor Jerry Sanders today joined UC San Diego Chancellor ... announce their support for a regional partnership designed to ... Speaking at a news conference on the UC San ... Diego region, now home to more than 500 biotechnology ...
... in U.S. dollars have been awarded to Singapore ... related to asthma and other immune system disorders, ... grants were awarded by the Biomedical Research Council ... Research), the government agency driving Singapore,s transformation into ...
... Ohio Very few athletic trainers associated with National ... following best practice standards for managing asthma among their ... with asthma, the dangers of the condition can be ... to be incapacitating, or deadly. The lead report is ...
Cached Biology News:Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Athletes with asthma need more help from their team trainers 2
(Date:5/5/2015)... GEA Pharma Systems, G-CON Manufacturing ... of the INTERPHEX Exhibitor Awards for 2015 for ... Continuous, Miniature and Modular (PCMM) platform. PCMM comprises ... processing equipment, smart control systems and PODs (portable, ... inactive ingredients into bulk tablets. , PCMM ...
(Date:5/4/2015)... , May 4, 2015 Many ... granted. But for certain infants with rare, inherited ... are stark consequences of their impaired immune responses. ... Center have identified an important role for calcium ... from Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... 2015 GliaCure, a privately-held biotechnology company ... neurological and neuropsychiatric disorders based on glial targets, ... patients in a Phase 1b clinical trial of ... as a potential disease-modifying treatment. GliaCure,s innovative approach ... it both promotes the clearance of amyloid and ...
(Date:5/4/2015)... May 4, 2015 /PRNewswire/ - The Fight Against ... pleased to announce the formation of Turnstone Biologics ... treatments for cancer that harness the patient,s own ... unique collaboration between the Children,s Hospital of ... McMaster University, the Ontario Institute for Cancer Research ...
Breaking Biology Technology:GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... Feb. 12 AdvanDx announced it has named,Else ... Dako A/S, as Vice,President of Sales and Marketing. ... AdvanDx,s fast, accurate and easy-to-use in vitro,molecular diagnostic ... infectious pathogens. Ms. Trautner previously managed an,organization of ...
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ... therapy and oncology, today reported that dosing of ... doxorubicin,has commenced in its Phase 2 trial in ... December 2007. This open-label,non-comparative multi-center Phase 2 trial ...
... Lasers to be Exclusively Featured in Leading Dental Education ... ... HOYA ConBio(TM), a global,leader in dental and aesthetic lasers, ... recognized dental education,company, in which VersaWave(TM) and DioDent(TM) Micro 980 ...
Cached Biology Technology:Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 3AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 4HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 3
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
... The 2/3D Waver Shaker combines shaking and ... with a 330 x 330 mm stainless steel ... top incubator and cold room operation. The platform ... degree for a vigorous with action and rotation ...
...
Biology Products: